HL7AU - FHIR WG : Meeting Notes: 2016-06-20

Attendance:  Stephen Chu (chair)

Stephen Royce (NEHTA)

Matthew Cordell (NEHTA)

Apology: Andrew Griffin

Minutes:

(1) Draft agenda:

• Attendance and apologies
• Approval of minutes of previous meeting
• HL7 Australia Medication Workgroup (WG) Mission & Charter
• HL7 Australia Medication Workgroup Decision Making Processes (DMP)
• Standards development strategy/Principle: adopt/adapt/create
• Review and localisation of international medication models/resources
• Medication WG Meeting schedules
• Membership drive

(2) Draft agenda reviewed and approved by attendees

(3) Meeting of previous meeting

Non of the attendees were at the previous Medication WG meeting (2016-05-09)

It was recommended and accepted that approval of the 2016-05-09 be deferred until the next meeting

(4) Walk through of draft documents:

• HL7 Australia Medication Workgroup Mission & Charter
• HL7 Australia Medication Workgroup Decision Making Processes (DMP)

These drafts are adapted/modified from HL7 International Pharmacy Workgroup Mission & Charter document and DMP document. International contents were replaced with Australian specific contents where appropriate.

These two documents will be posted onto HL7 Australia Medication WG confluence page for members review and inputs.

Plan is to finalised the review and approve the documents at the next workgroup meeting (July)

(5) Attendees approved the proposed standards development strategy/principle:

• adopt before adapt and before create
  • Adopt international and national medication and related standards where available
  • Adapt where international and national standards components require customerisation/localisation
  • Create as the last measure

 (6) International medication models/resources

The attendees had a quick overview of the HL7/FHIR resources:

• • Medication
  • MedicationOrder
  • MedicationDispense
  • MedicationAdministration
  • MedicationStatement
  • Immunization
  • ImmunizationRecommendation

The attendees agreed that the FHIR resources are good starting points to consider the Medication WG work program for the upcoming 12 months. The plan is to pick high priority resources that will add value to the Australian digital health stakeholders; and to develop work plan accordingly. This will be discussed in details at the next meeting/at a meeting with more participants.

It was also proposed that related and relevant resources should also need to be considered:

• • Allergy/Intolerance
  • Adverse reactions

These are important as they are closely related to all 7 Medication resources.

Adverse event was also identified as one that needs to be considered, but at a lower priority.

(7) Medication WG meeting schedule

It was agreed that the Medication WG will hold monthly meetings - last Monday of each month

Ad hoc meeting can be convened when necessary

(8) Membership drive

The attendees acknowledged the importance to have broader and more members participating and contributing to the group.

HL7 Australia is actively promoting participation by jurisdiction, e.g. NSW. Other jurisdiction Health Departments should also be invited to participate.

Members of this group can also proactively invite participation from hospitals.

Andrew (co-chair) to reach out to pharmacy community to encourage participation